Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and many target applications, the biotechnology, agricultural, and pharmaceutical fields are pushing full speed ahead into this promising field. Helping spur
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S. Court of Appeals for the Federal Circuit affirmed a district court decision invalidating a patent claim where, more than one
Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid nanoparticle (LNP) pioneers. Since this is the most significant happening in this space with respect to IP in 2022, this
Great buzz resulted from the World Bank study showing that the fashion industry is responsible for about 10% of annual global carbon emissions – more than international flights and maritime shipping combined[1]. While this news may not come
Web3, the up-and-coming decentralized iteration of the World Wide Web built on the blockchain, presents a unique opportunity for fashion brands to provide consumers with phygital—physical plus digital—experiences. Creating phygital experiences gives fashion brands the powerful opportunity to merge the
Spurred by the vast potential of artificial intelligence (AI) and machine learning (ML) technologies, many countries are evaluating whether existing legal frameworks for intellectual property (IP) protection are adequate or need to adapt in order to promote key policy objectives
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the past year relating to sales of the Moderna and BioNTech/Pfizer COVID-19 vaccine products (Spikevax® and Comirnaty®, respectively). This post provides
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating to the discovery, development and commercialization of therapeutics and vaccines in the oncology and infectious disease spaces.
The deal centers
On April 13, 2022, the European Commission submitted a proposed regulation on the protection of Geographical Indications for Craft and Industrial Products (CIPs), along with amendments to existing EU regulations on trademark registration and accession to the Geneva Act of
Introduction
For many start-up companies, the prospect of filing a patent application can be daunting. Even when a company has a potentially patentable invention, the company may be unsure about what materials it should compile before seeking out patent counsel.
